Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study – New Study
Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study
Summary
A Turkish Oncology Group study investigated the prognostic and predictive value of systemic inflammatory markers (like neutrophil-to-lymphocyte ratio) in metastatic gastric and gastroesophageal junction (GEJ) adenocarcinoma patients with a PD-L1 Combined Positive Score (CPS) ≥ 5. The research aimed to determine if these readily available markers can predict treatment outcomes and survival in this specific patient subgroup, potentially guiding personalized treatment strategies. The study highlights the importance of considering inflammatory markers alongside PD-L1 status for better clinical decision-making in advanced gastric cancer.
Read more…
Credits: Source
This post is part of “Science/Immunology News”, Follow for more…!!!